Le Lézard
Classified in: Health, Science and technology

H-Source Announces Move to EY OpsChain Blockchain Platform


VANCOUVER, Sept. 23, 2019 /PRNewswire/ - H-Source Holdings Ltd. (TSXV: HSI; OTCQB: HSCHF) (the "Company" or "H-Source") is pleased to announce that it is expanding its technology offering by moving to the EY OpsChain blockchain platform in order to facilitate greater opportunities in healthcare.

"The H-Source platform is currently built with robust GS-1, UDI/GTIN and DSCSA "Track and Trace" capabilities. Combining our platform with the best in class EY OpsChain will be a significant step forward in our mission to provide new healthcare solutions in the US and Globally," said John Kupice, CEO/director of H-Source. "The H-Source vision of supply chain transformation facilitating communication and collaboration to drive efficiencies, combines well with the EY focus on making connections a key component of global health. We appreciate the opportunity to work with EY on new initiatives."

"We're excited to support H-Source in enabling the healthcare industry to access the products and tools they need more sustainably," says Abhishek Sinha, EY Canada Blockchain Leader. "EY OpsChain helps companies simplify supply chain management and seamlessly integrate everything from digital contracts and shared inventory to logistics information."

"Scaling and industrializing privacy technology has been a big priority for EY," says Paul Brody, EY Global Blockchain Leader. "H-Source will be one of the very first commercial implementations of EY OpsChain and we're very proud of our work for H-Source on this front."

About H-Source Holdings Ltd.
H-Source Holdings Ltd. is a technology company operating within the healthcare industry through its wholly owned subsidiaries, H-Source, Inc. and H-Source Distribution, Inc. The Company has developed a private, secure, and trusted transaction platform that allows member medical facilities including hospitals and ASC's (Ambulatory Surgery Centers) to buy, sell, track, and transfer medical devices and supplies, pharmaceuticals, and capital equipment with each other. Member medical facilities can conduct secure transactions within their private groups or global platform members. This marketplace network is specifically designed to reduce health care costs and medical product waste, increase cost recovery, and enable supply chain transformation and efficiency. For more information, please visit http://h-source.com/.

On behalf of the board of directors of H-Source Holdings Ltd.

"John Kupice"
John Kupice
CEO & Director

CAUTIONARY DISCLAIMER STATEMENT: The TSXV has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.

This news release contains forward-looking statements relating to the completion of the listing of the Company's shares on the TSXV and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company's expectations include the failure to satisfy the conditions of the TSXV and other risks detailed from time to time in the filings made by the Company with securities regulations.

The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements as expressly required by applicable law.

SOURCE H-Source Holdings Ltd.


These press releases may also interest you

at 03:00
ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs, today announced an oral presentation at the upcoming Oligonucleotide & Peptide Therapeutics (TIDES) Conference...

at 02:32
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred ? medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications...

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...



News published on and distributed by: